Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
- 11 April 2000
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (14) , 1634-1637
- https://doi.org/10.1161/01.cir.101.14.1634
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Functional Consequences of Altering Myocardial Adrenergic Receptor SignalingAnnual Review of Physiology, 2000
- Defective β-Adrenergic Receptor Signaling Precedes the Development of Dilated Cardiomyopathy in Transgenic Mice with Calsequestrin OverexpressionPublished by Elsevier ,1999
- Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene deliveryJournal of Clinical Investigation, 1999
- Adenovirus-mediated gene transfer of the β2-adrenergic receptor to donor hearts enhances cardiac functionGene Therapy, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted MicePublished by Elsevier ,1998
- Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted miceProceedings of the National Academy of Sciences, 1998
- G PROTEIN–COUPLED RECEPTOR KINASESAnnual Review of Biochemistry, 1998
- Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic ReceptorScience, 1994
- The development of positive inotropic agents for chronic heart failure: How have we gone astray?Journal of the American College of Cardiology, 1993